Deprescribing in migraine

New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database

(2021) Maurizio Sessa et al.   BIODRUGS

Rapid referral for headache management from emergency department to headache centre: four years data

(2020) Andrea Negro et al.   JOURNAL OF HEADACHE AND PAIN

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies

(2020) Kristian Agmund Haanes et al.   JOURNAL OF HEADACHE AND PAIN

European headache federation consensus on the definition of resistant and refractory migraine

(2020) Simona Sacco et al.   JOURNAL OF HEADACHE AND PAIN

Combination therapy in migraine: asset or issue?

(2020) Paolo Martelletti   Expert Review of Neurotherapeutics

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019

(2020) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

(2019) Simona Sacco et al.   JOURNAL OF HEADACHE AND PAIN

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?

(2019) Valentina Favoni et al.   JOURNAL OF HEADACHE AND PAIN

Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)

(2019) Paolo Martelletti et al.   JOURNAL OF HEADACHE AND PAIN

Aids to management of headache disorders in primary care (2nd edition)

(2019) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Optimising migraine treatment: from drug-drug interactions to personalized medicine

(2019) Leda Marina Pomes et al.   JOURNAL OF HEADACHE AND PAIN

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

(2018) Lars Bendtsen et al.   JOURNAL OF HEADACHE AND PAIN

Drug safety and tolerability in prophylactic migraine treatment

(2015) László Vécsei et al.   Expert Opinion On Drug Safety